Montauk Renewables MNTK 深 沪
等待开盘 08-04 09:30:00 美东时间
2.06
-0.110
-5.07%
华盛通- 最 高2.13
- 今 开2.11
- 成交量 12.38万股
- 最 低 2.05
- 昨 收 2.17
- 总市值 2.93亿
- 52周最高 6.04
- 市盈率 静 30.12
- 换手率 0.09%
- 52周最低 1.68
- 委 比 4.11%
- 总股本 1.42亿
- 历史最高 20.78
- 量 比 0.89
- 振 幅 3.69%
- 历史最低 1.68
- 每 手 1
- 风险率 1.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Montauk Renewables Schedules Second Quarter 2025 Conference Call for Thursday, August 7, 2025, at 8:30 a.m. ET
Montauk Renewables Inc. (NASDAQ: MNTK), a renewable energy company specializing in biogas-to-RNG conversion, will host a conference call and webcast on August 7, 2025, at 8:30 a.m. ET to discuss its Q2 2025 financial results. Participants should register in advance via the provided link, which will provide dial-in details and access pins. A replay will be available post-event. The company captures methane and converts it into RNG or renewable ele...
07-24 20:30
Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Wed...
07-02 22:22
Montauk Renewables shares are trading lower. The company reported Q1 financial results.
Montauk Renewables shares are trading lower. The company reported Q1 financial ...
05-09 04:54
Montauk Renewables Q1 Sales $42.60M Beat $42.40M Estimate
Montauk Renewables (NASDAQ:MNTK) reported quarterly sales of $42.60 million which beat the analyst consensus estimate of $42.40 million by 0.48 percent. This is a 9.84 percent increase over sales of $38.79 million the
05-09 04:39
Montauk Renewables Affirms FY2025 Sales Guidance of $167.00M-$188.00M vs $179.61M Est
Montauk Renewables (NASDAQ:MNTK) affirms FY2025 sales outlook from $167.00 million-$188.00 million to $167.00 million-$188.00 million vs $179.61 million estimate.
05-09 04:39
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
Montauk Renewables announces $5M share repurchase program
Montauk Renewables (NASDAQ:MNTK) has announced a new $5 million share repurchase program authorized by its Board of Directors. The program allows for the repurchase of up to $5 million of the company'...
04-16 12:32
美股大行评级 | 潜在涨幅223.78%！内克塔治疗获杰富瑞升目标价至2美元，上调至"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117736711687032832.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 杰富瑞：上调内克塔治疗(NKTR)评级至"买入"，目标价从1美元升至2美元</p> <p>• Roth MKM：维持Lovesac Co.(LOVE)"买入"评级，目标价从22美元升至28美元</p> <p>• Macq
04-14 07:05
Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 450 points on ...
03-24 22:10
美股大行评级 | Tigress Financial：维持爱彼迎"买入"评级，目标价从195美元升至200美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107588488073326592.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持ProQR Therapeutics(PRQR)"买入"评级，目标价从10美元升至12美元</p> <p>• Oppenheimer：上调内克塔治疗(NKTR)评级至"跑
03-17 10:10
